Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kolditz

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Deutsches Arzteblatt International|March 23, 2018
In ReplyMartin Kolditz
European Journal of Internal Medicine|October 1, 2025
Not all immunosuppression is equal: Implications for post-discharge outcomes in community-acquired pneumonia - Authors' replyFabian Reichel, Martin Kolditz
MMW Fortschritte Der Medizin|January 29, 2010
[Decision guidance for antibiotic treatment of acute exacerbation of COPD]Martin Kolditz, Gert Höffken
Deutsches Arzteblatt International|December 23, 2017
Community-Acquired Pneumonia in AdultsMartin Kolditz, Santiago Ewig
Deutsche Medizinische Wochenschrift (1946)|July 28, 2019
[Legionella and Legionellosis]Martin Kolditz, Christian Lück
The European Respiratory Journal|February 12, 2021
Preventing cardiovascular events after pneumonia with aspirin: one step forward, but still many to goMartin Kolditz, Tobias Welte
Chest|December 7, 2020
Community-Acquired Pneumonia in Immunocompromised Adults: Solid Tumors Might Not Be Regarded as Independent Risk Factors for Opportunistic PathogensMartin Kolditz, Santiago Ewig
Treatments in Respiratory Medicine|August 10, 2005
Short-course antimicrobial therapy for community-acquired pneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Treatments in Respiratory Medicine|December 13, 2006
Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired PneumoniaMartin Kolditz, Michael Halank, Gert Höffken
The European Respiratory Journal|September 29, 2012
Management-based risk prediction in community-acquired pneumonia by scores and biomarkersMartin Kolditz, Santiago Ewig, Gert Höffken
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Deutsches Arzteblatt International|March 23, 2018
In ReplyMartin Kolditz
European Journal of Internal Medicine|October 1, 2025
Not all immunosuppression is equal: Implications for post-discharge outcomes in community-acquired pneumonia - Authors' replyFabian Reichel, Martin Kolditz
MMW Fortschritte Der Medizin|January 29, 2010
[Decision guidance for antibiotic treatment of acute exacerbation of COPD]Martin Kolditz, Gert Höffken
Deutsches Arzteblatt International|December 23, 2017
Community-Acquired Pneumonia in AdultsMartin Kolditz, Santiago Ewig
Deutsche Medizinische Wochenschrift (1946)|July 28, 2019
[Legionella and Legionellosis]Martin Kolditz, Christian Lück
The European Respiratory Journal|February 12, 2021
Preventing cardiovascular events after pneumonia with aspirin: one step forward, but still many to goMartin Kolditz, Tobias Welte
Chest|December 7, 2020
Community-Acquired Pneumonia in Immunocompromised Adults: Solid Tumors Might Not Be Regarded as Independent Risk Factors for Opportunistic PathogensMartin Kolditz, Santiago Ewig
Treatments in Respiratory Medicine|August 10, 2005
Short-course antimicrobial therapy for community-acquired pneumoniaMartin Kolditz, Michael Halank, Gert Höffken
Treatments in Respiratory Medicine|December 13, 2006
Monotherapy versus Combination Therapy in Patients Hospitalized with Community-Acquired PneumoniaMartin Kolditz, Michael Halank, Gert Höffken
The European Respiratory Journal|September 29, 2012
Management-based risk prediction in community-acquired pneumonia by scores and biomarkersMartin Kolditz, Santiago Ewig, Gert Höffken
Pageof 7